2-38296104-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001135673.4(ATL2):c.1642C>T(p.Pro548Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000265 in 1,398,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001135673.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.000115 AC: 18AN: 155930Hom.: 0 AF XY: 0.0000848 AC XY: 7AN XY: 82554
GnomAD4 exome AF: 0.0000265 AC: 37AN: 1398318Hom.: 0 Cov.: 31 AF XY: 0.0000304 AC XY: 21AN XY: 689678
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1642C>T (p.P548S) alteration is located in exon 13 (coding exon 13) of the ATL2 gene. This alteration results from a C to T substitution at nucleotide position 1642, causing the proline (P) at amino acid position 548 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at